🇺🇸 FDA
Pipeline program

UGN-104

UT002

Phase 3 small_molecule active

Quick answer

UGN-104 for Low-grade Upper Tract Urothelial Cancer is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Low-grade Upper Tract Urothelial Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials